ArticleAnatomical science international2026
The difference in immunohistochemical reactivity of monoclonal antibodies against amino-terminal residues of amyloid-β peptide.
Article in Anatomical science international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metal-organic macrocycles as molecular modulators of amyloid-β aggregation and cytotoxicity.Chemical science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Immunohistochemistry for amyloid-β peptide is a valuable method for Alzheimer's disease research. Despite a wide variety of available antibodies against the peptides, the difference of immunohistochemical reactivity is not fully described among them. Immunohistochemical reactivity of amyloid-β antibodies is critical for accurate and reliable evaluation of amyloid-β burden in patients as well as models of Alzheimer's disease. Here, we examined immunohistochemical reactivity of two mouse and one rabbit monoclonal antibodies against the N-terminal region of amyloid-β peptides using two Alzheimer's disease mouse models, App
Indexed as
Identifiers
41505017What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.